Clinical trial
Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
NCT03947749 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
- Lead sponsor
- University of Florida
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 25, 2019
- Completion date
- April 6, 2023
- Enrollment
- 275 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pain, chronic, prescription drug abuse (not dependent)